Prenatal sleep health and risk of offspring ADHD symptomatology and associated phenotypes: a prospective analysis of timing and sex differences in the ECHO cohort.

Intergenerational transmission Offspring ADHD Prenatal sleep health

Journal

Lancet regional health. Americas
ISSN: 2667-193X
Titre abrégé: Lancet Reg Health Am
Pays: England
ID NLM: 9918232503006676

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 24 03 2023
revised: 12 09 2023
accepted: 21 09 2023
medline: 18 12 2023
pubmed: 18 12 2023
entrez: 18 12 2023
Statut: epublish

Résumé

Sleep difficulties are common in pregnancy, yet poor prenatal sleep may be related to negative long-term outcomes for the offspring, including risk for attention-deficit/hyperactivity disorder (ADHD). Existing studies are few and have not examined timing of exposure effects or offspring sex moderation. We thus aimed to test the hypotheses that poor sleep health in pregnancy is associated with increased risk for ADHD symptoms and offspring sleep problems at approximately 4 years of age. Participants were 794 mother-child dyads enrolled in the NIH Environmental Influences on Child Health Outcomes Study (ECHO). Participants self-reported on sleep duration, quality, and disturbances during pregnancy and on children's ADHD symptoms and sleep problems on the Child Behaviour Checklist. Pregnant participants were 32.30 ± 5.50 years and children were 46% female. 44 percent of pregnant participants identified as Hispanic or Latine; 49% identified as White. Second-trimester sleep duration was associated with offspring ADHD symptoms ( Poor prenatal sleep health, particularly quality and duration in the second trimester, may be associated with offspring risk of neurodevelopmental disorders and sleep problems in early childhood. Further research is needed to understand mechanisms, yet our study suggests that prenatal maternal sleep may be a modifiable target for interventions aimed at optimizing early neurodevelopment. NIH grants U2COD023375, U24OD023382, U24OD023319, UH3OD023320, UH3OD023305, UH3OD023349, UH3OD023313, UH3OD023272, UH3OD023328, UH3OD023290, K08MH117452 and NARSAD Young Investigator Award 28545.

Sections du résumé

Background UNASSIGNED
Sleep difficulties are common in pregnancy, yet poor prenatal sleep may be related to negative long-term outcomes for the offspring, including risk for attention-deficit/hyperactivity disorder (ADHD). Existing studies are few and have not examined timing of exposure effects or offspring sex moderation. We thus aimed to test the hypotheses that poor sleep health in pregnancy is associated with increased risk for ADHD symptoms and offspring sleep problems at approximately 4 years of age.
Methods UNASSIGNED
Participants were 794 mother-child dyads enrolled in the NIH Environmental Influences on Child Health Outcomes Study (ECHO). Participants self-reported on sleep duration, quality, and disturbances during pregnancy and on children's ADHD symptoms and sleep problems on the Child Behaviour Checklist.
Findings UNASSIGNED
Pregnant participants were 32.30 ± 5.50 years and children were 46% female. 44 percent of pregnant participants identified as Hispanic or Latine; 49% identified as White. Second-trimester sleep duration was associated with offspring ADHD symptoms (
Interpretation UNASSIGNED
Poor prenatal sleep health, particularly quality and duration in the second trimester, may be associated with offspring risk of neurodevelopmental disorders and sleep problems in early childhood. Further research is needed to understand mechanisms, yet our study suggests that prenatal maternal sleep may be a modifiable target for interventions aimed at optimizing early neurodevelopment.
Funding UNASSIGNED
NIH grants U2COD023375, U24OD023382, U24OD023319, UH3OD023320, UH3OD023305, UH3OD023349, UH3OD023313, UH3OD023272, UH3OD023328, UH3OD023290, K08MH117452 and NARSAD Young Investigator Award 28545.

Identifiants

pubmed: 38106969
doi: 10.1016/j.lana.2023.100609
pii: S2667-193X(23)00183-7
pmc: PMC10725065
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100609

Subventions

Organisme : NIH HHS
ID : U2C OD023375
Pays : United States
Organisme : NIMH NIH HHS
ID : K08 MH117452
Pays : United States
Organisme : NIH HHS
ID : UG3 OD023320
Pays : United States
Organisme : NIH HHS
ID : UG3 OD035546
Pays : United States
Organisme : NIH HHS
ID : U24 OD023319
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023305
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023272
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES030284
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023320
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023328
Pays : United States
Organisme : NIH HHS
ID : U24 OD023382
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023313
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023349
Pays : United States
Organisme : NIH HHS
ID : UG3 OD035513
Pays : United States

Informations de copyright

© 2023 The Author(s).

Déclaration de conflit d'intérêts

All authors declare no competing interests. CLC, CD, JA and AM all report funding from NIH. CD reports funding form Morgan Stanley, Saks Foundation, payments from WT Grant Foundation and UC Davies College of Biological Sciences and a leadership role in the American Psychopathological Association. JA reports honoraria from IPOKRaTES Neonatology Conference and holding a leadership position in National Board of Trustees: March of Dimes. SD reports payment or honoraria from Nestle Nutrition, Wyeth. Nutrition and Mead Johnson Nutrition.

Références

Sci Rep. 2020 Apr 29;10(1):7228
pubmed: 32350333
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
Int J Mol Sci. 2019 May 08;20(9):
pubmed: 31071949
J Abnorm Psychol. 2019 Jan;128(1):81-95
pubmed: 30628810
Best Pract Res Clin Obstet Gynaecol. 2014 Jan;28(1):25-35
pubmed: 24090740
J Endocrinol Invest. 2009 Mar;32(3):279-83
pubmed: 19542749
Sleep Med Rev. 2020 Apr;50:101234
pubmed: 31801099
Sci Rep. 2020 Jul 6;10(1):11084
pubmed: 32632276
Behav Sleep Med. 2016;14(3):267-78
pubmed: 26244485
Sleep Med Rev. 2018 Oct;41:197-219
pubmed: 29910107
Compr Psychiatry. 2020 Feb 14;98:152168
pubmed: 32105909
Curr Psychiatry Rep. 2019 Mar 2;21(3):17
pubmed: 30826879
Front Pediatr. 2014 Sep 03;2:93
pubmed: 25232537
Epidemiol Psychiatr Sci. 2019 Oct;28(5):521-531
pubmed: 29665879
Acta Paediatr. 2002;91(5):584-92
pubmed: 12113330
Behav Sleep Med. 2013;11(3):207-21
pubmed: 23205562
J Reprod Immunol. 2007 Apr;73(2):158-165
pubmed: 17074396
Brain Res. 2015 Jan 30;1596:88-98
pubmed: 25446439
Sleep. 2022 Sep 8;45(9):
pubmed: 35724979
Sci Rep. 2018 May 3;8(1):6963
pubmed: 29725029
Sleep Health. 2019 Dec;5(6):615-620
pubmed: 31685440
Psychol Med. 2019 Sep;49(12):2081-2090
pubmed: 30293538
Ment Retard Dev Disabil Res Rev. 2005;11(3):226-37
pubmed: 16161094
Sci Rep. 2015 Apr 01;5:9513
pubmed: 25830666
J Sleep Res. 2021 Jun;30(3):e13135
pubmed: 32618040
J Anxiety Disord. 2016 Jan;37:78-88
pubmed: 26735330
Neurobiol Dis. 2014 Aug;68:57-65
pubmed: 24769004
Womens Health Issues. 2009 Jan-Feb;19(1):45-51
pubmed: 19111787
Sci Rep. 2021 Jun 4;11(1):11834
pubmed: 34088929
Int J Dev Neurosci. 2018 Oct;69:60-67
pubmed: 29959981
Sleep Med Rev. 2019 Dec;48:101208
pubmed: 31491656
Front Psychiatry. 2020 Jun 19;11:547
pubmed: 32636769
Obstet Gynecol Surv. 2009 Apr;64(4):273-80
pubmed: 19296861

Auteurs

Claudia Lugo-Candelas (C)

New York State Psychiatric Institute/Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY, 10032, USA.

Tse Hwei (T)

New York State Psychiatric Institute/Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY, 10032, USA.

Seonjoo Lee (S)

New York State Psychiatric Institute/Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY, 10032, USA.

Maristella Lucchini (M)

Research Department, Nanit, 122 Grand St, New York, NY, 10013, USA.

Alice Smaniotto Aizza (A)

New York State Psychiatric Institute/Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY, 10032, USA.

Linda G Kahn (LG)

NYU Grossman School of Medicine, 227 East 34th Street, Room 811, New York, NY, 10016, USA.

Claudia Buss (C)

Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Luisenstrasse 57, 10117, Berlin, Germany.

Thomas G O'Connor (TG)

University of Rochester, 300 Crittenden Blvd, Rochester, NY, 14642, USA.

Akhgar Ghassabian (A)

NYU Grossman School of Medicine, 227 East 34th Street, Room 811, New York, NY, 10016, USA.

Amy M Padula (AM)

University of California, San Francisco, 490 Illinois Street, Box 0132, San Francisco, CA, 94158, USA.

Judy Aschner (J)

Hackensack Meridian School of Medicine, Nutley NJ and Albert Einstein College of Medicine, Bronx, NY, USA.

Sean Deoni (S)

Bill & Melinda Gates Foundation, 500 Mercer Str, Seattle, WA, 98275, USA.

Amy E Margolis (AE)

New York State Psychiatric Institute/Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY, 10032, USA.

Glorisa Canino (G)

University of Puerto Rico Medical Sciences Campus, Behavioral Sciences Research Institute, 9th Floor, Rio Piedras, PR, 00935, Puerto Rico.

Catherine Monk (C)

New York State Psychiatric Institute/Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY, 10032, USA.

Jonathan Posner (J)

Duke University, North Pavilion Building, 2400 Pratt Street, Durham, NC, 27705, USA.

Cristiane S Duarte (CS)

New York State Psychiatric Institute/Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY, 10032, USA.

Classifications MeSH